Evidence map›Paper›PMID 30175557›Full record

Trial reportPhysiological reports2018

Changes in metabolism but not myocellular signaling by training with CHO-restriction in endurance athletes.

Kasper D Gejl, Kristian Vissing, Mette Hansen, Line Thams, Torben Rokkedal-Lausch, Peter Plomgaard, Anne-Kristine Meinild Lundby, Lars Nybo, Kurt Jensen, Hans-Christer Holmberg and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Physiological reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Kasper D GejlDepartment of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.
Kristian VissingDepartment of Public Health, Section for Sport Science, Aarhus University, Aarhus, Denmark.
Mette HansenDepartment of Public Health, Section for Sport Science, Aarhus University, Aarhus, Denmark.
Line ThamsDepartment of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.
Torben Rokkedal-LauschSMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg, Denmark.
Peter PlomgaardDepartment of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark.
Anne-Kristine Meinild LundbyThe Centre of Inflammation and Metabolism, Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Lars NyboDepartment of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
Kurt JensenDepartment of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.
Hans-Christer HolmbergSwedish Winter Sports Research Centre, Department of Health Sciences, Mid Sweden University, Östersund, Sweden.
Niels ØrtenbladDepartment of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.
University of Southern Denmark · DKAarhus University · DKMid Sweden University · SEAalborg University · DKCopenhagen University Hospital · DKRigshospitalet · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbohydrate (CHO) restricted training has been shown to increase the acute training response, whereas less is known about the acute effects after repeated CHO restricted training. On two occasions, the acute responses to CHO restriction were examined in endurance athletes. Study 1 examined cellular signaling and metabolic responses after seven training-days including CHO manipulation (n = 16). The protocol consisted of 1 h high-intensity cycling, followed by 7 h recovery, and 2 h of moderate-intensity exercise (120SS). Athletes were randomly assigned to low (LCHO: 80 g) or high (HCHO: 415 g) CHO during recovery and the 120SS. Study 2 examined unaccustomed exposure to the same training protocol (n = 12). In Study 1, muscle biopsies were obtained at rest and 1 h after 120SS, and blood samples drawn during the 120SS. In Study 2, substrate oxidation and plasma glucagon were determined. In Study 1, plasma insulin and proinsulin C-peptide were higher during the 120SS in HCHO compared to LCHO (insulin: 0 min: +37%; 60 min: +135%; 120 min: +357%, P = 0.05; proinsulin C-peptide: 0 min: +32%; 60 min: +52%; 120 min: +79%, P = 0.02), whereas plasma cholesterol was higher in LCHO (+15-17%, P = 0.03). Myocellular signaling did not differ between groups. p-AMPK and p-ACC were increased after 120SS (+35%, P = 0.03; +59%, P = 0.0004, respectively), with no alterations in p-p38, p-53, or p-CREB. In Study 2, glucagon and fat oxidation were higher in LCHO compared to HCHO during the 120SS (+26-40%, P = 0.03; +44-76%, P = 0.01 respectively). In conclusion, the clear respiratory and hematological effects of CHO restricted training were not translated into superior myocellular signaling after accustomization to CHO restriction.

Indexed as

Signal TransductionAdultAMP-Activated Protein Kinase KinasesCholesterolCyclic AMP Response Element-Binding ProteinDiet, Carbohydrate-RestrictedEndurance TrainingGlucagonHumansInsulinLipid MetabolismMaleMuscle CellsProtein KinasesAMP-Activated Protein Kinase KinasesCholesterolCyclic AMP Response Element-Binding ProteinGlucagonInsulinProtein KinasesCyclingendurance performancefat oxidationglycogentrain-low

Identifiers

PMID30175557
PMCPMC6119686
OpenAlexW2892277548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.